Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000907420 | SCV001052124 | likely benign | not provided | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003259013 | SCV003949792 | uncertain significance | Inborn genetic diseases | 2023-05-09 | criteria provided, single submitter | clinical testing | The c.752A>G (p.N251S) alteration is located in exon 4 (coding exon 4) of the LRP6 gene. This alteration results from a A to G substitution at nucleotide position 752, causing the asparagine (N) at amino acid position 251 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003923094 | SCV004738670 | benign | LRP6-related disorder | 2019-09-09 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |